Related references
Note: Only part of the references are listed.Current trends in the use of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) in neurooncology
Carina Stegmayr et al.
NUCLEAR MEDICINE AND BIOLOGY (2021)
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
Lakshmi Nayak et al.
CLINICAL CANCER RESEARCH (2021)
Cancer Stem Cells in Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma Express Components of the Renin-Angiotensin System
Sam Siljee et al.
CELLS (2021)
Expression of Components of the Renin-Angiotensin System by Cancer Stem Cells in Renal Clear Cell Carcinoma
Sam Siljee et al.
BIOMOLECULES (2021)
The Role of the Renin-Angiotensin System in the Cancer Stem Cell Niche
Ethan J. Kilmister et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2021)
The Renin-Angiotensin System in the Tumor Microenvironment of Glioblastoma
Michael O'Rawe et al.
CANCERS (2021)
Impact of adverse events of bevacizumab on survival outcomes of patients with recurrent glioblastoma
Carlos Kamiya-Matsuoka et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2020)
Margin reduction in radiotherapy for glioblastoma through 18F-fluoroethyltyrosine PET? - A recurrence pattern analysis
Daniel F. Fleischmann et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Nanocarrier-based drug combination therapy for glioblastoma
Mengnan Zhao et al.
THERANOSTICS (2020)
Expression of cancer stem cell markers in metastatic melanoma to the brain
Agadha C. Wickremesekera et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2019)
(Pro)renin receptor regulates lung development via the Wnt/β-catenin signaling pathway
Jie Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2019)
Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment
Rut Tejero et al.
EBIOMEDICINE (2019)
Therapeutic Targeting of Cancer Stem Cells in Human Glioblastoma by Manipulating the Renin-Angiotensin System
David C. H. Tan et al.
CELLS (2019)
FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma
Philipp Lohmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Cancer stem cells within moderately differentiated head and neck cutaneous squamous cell carcinoma express components of the renin-angiotensin system
Shanella Nallaiah et al.
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2019)
The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials
Maryam Moradi Binabaj et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Life beyond a diagnosis of glioblastoma: a systematic review of the literature
L. Gately et al.
JOURNAL OF CANCER SURVIVORSHIP (2017)
Cyclooxygenase-2 Inhibition Limits Angiotensin II-Induced DNA Oxidation and Protein Nitration in Humans
Vincent Pialoux et al.
FRONTIERS IN PHYSIOLOGY (2017)
Advanced magnetic resonance imaging in glioblastoma: a review
Gaurav Shukla et al.
CHINESE CLINICAL ONCOLOGY (2017)
Cancer Stem Cells in Moderately Differentiated Lip Squamous Cell Carcinoma Express Components of the Renin-Angiotensin System
Rachna S. Ram et al.
FRONTIERS IN SURGERY (2017)
Expression of Cathepsins B, D, and G in Isocitrate Dehydrogenase-Wildtype Glioblastoma
Sabrina P. Koh et al.
FRONTIERS IN SURGERY (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Cancer stem cells in moderately differentiated oral tongue squamous cell carcinoma
Ranui Baillie et al.
JOURNAL OF CLINICAL PATHOLOGY (2016)
Caffeine suppresses the progression of human glioblastoma via cathepsin B and MAPK signaling pathway
Yu-Chen Cheng et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2016)
Cancer stem cells in glioblastoma
Justin D. Lathia et al.
GENES & DEVELOPMENT (2015)
Podocalyxin promotes glioblastoma multiforme cell invasion and proliferation by inhibiting angiotensin-(1-7)/Mas signaling
Bo Liu et al.
ONCOLOGY REPORTS (2015)
Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma
Rasime Kalkan
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2015)
CUSP9*treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide
Richard E. Kast et al.
ONCOTARGET (2014)
Stem Cell Niches in Glioblastoma: A Neuropathological View
Davide Schiffer et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression
Sreelatha Gopinath et al.
CARCINOGENESIS (2013)
The Renin-angiotensin System as a Target of Novel Anticancer Therapy
Katarzyna Regulska et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Angiogenesis in Glioblastoma
Sunit Das et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Metformin Downregulates the Insulin/IGF-I Signaling Pathway and Inhibits Different Uterine Serous Carcinoma (USC) Cells Proliferation and Migration in p53-Dependent or -Independent Manners
Rive Sarfstein et al.
PLOS ONE (2013)
A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.
Richard E. Kast et al.
ONCOTARGET (2013)
Pathobiological aspects of the local bone marrow renin-angiotensin system: a review
Ibrahim C. Haznedaroglu et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2010)
Colorectal Cancer: Chemopreventive Role of Curcumin and Resveratrol
Vaishali B. Patel et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2010)
Curcumin, the Golden Spice From Indian Saffron, Is a Chemosensitizer and Radiosensitizer for Tumors and Chemoprotector and Radioprotector for Normal Organs
Ajay Goel et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2010)
Renin angiotensin system and hemangioblast development from human embryonic stem cells
Igor I. Slukvin
EXPERT REVIEW OF HEMATOLOGY (2009)
The renin-angiotensin system and malignancy
Eleanor I. Ager et al.
CARCINOGENESIS (2008)
Effects of renin-angiotensin system inhibition on end-organ protection: Can we do better?
Matthew R. Weir
CLINICAL THERAPEUTICS (2007)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
R Galli et al.
CANCER RESEARCH (2004)
Marked suppression of renin levels by β-receptor blocker in patients treated with standard heart failure therapy:: a potential mechanism of benefit from β-blockade
SR Holmer et al.
JOURNAL OF INTERNAL MEDICINE (2001)
Share Paper
